Filing Details

Accession Number:
0001127602-23-024195
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-09-14 16:41:48
Reporting Period:
2023-09-12
Accepted Time:
2023-09-14 16:41:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1531048 Inari Medical Inc. NARI Surgical & Medical Instruments & Apparatus (3841) 452902923
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1644989 Hill, Mitch C. C/O Inari Medical, Inc.
6001 Oak Canyon
Irvine CA 92618
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-09-12 6,500 $0.46 178,302 No 4 M Direct
Common Stock Disposition 2023-09-12 1,055 $66.59 177,247 No 4 S Direct
Common Stock Disposition 2023-09-12 2,120 $67.70 175,127 No 4 S Direct
Common Stock Disposition 2023-09-12 3,325 $68.35 171,802 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2023-09-12 6,500 $0.00 6,500 $0.46
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
113,977 2029-04-23 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,600 Indirect By Spouse
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022.
  2. This transaction was executed in multiple trades at prices ranging from $66.11 to $66.89. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. This transaction was executed in multiple trades at prices ranging from $67.15 to $68.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. This transaction was executed in multiple trades at prices ranging from $68.15 to $68.91. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  5. Options vested with respect to 25% of the shares on April 30, 2020 and vest with respect to the remaining shares in 36 equal monthly installments thereafter.